The growing interest in successful weight management has spurred considerable investigation into groundbreaking treatments. Lately , Retatrutide, a dual -action hormone and glucagon-like peptide-1 (GLP-1) receptor agonist , has exhibited positive results in medical trials, indicating potential fo